0 Items
Select Page

Hantavirus

Hantaviruses are a family of rodent-borne viruses that cause clinical illness in humans of varying severity. Transmission of the virus to humans occurs through the inhalation of infected rodent urine, droppings, or saliva.

The Native Antigen Company are pleased to offer monoclonal antibodies specific to Hantavirus, that bind to several members of the Hantavirus family.

Hantavirus Background

Hantaviruses (HTNV) are a family of viruses within the order Bunyaviridae. The Hantavirus genome is comprised of three segments of single-stranded negative-sense RNA, which are named based on their size: small (S), medium (M) and large (L). The L segment encodes viral polymerase, the M segment encodes the precursor (GPC) for two viral surface glycoproteins (Gn and Gc), and the S segment encodes the nucleocapsid (N) protein. The N protein is highly conserved in Hantaviruses and plays a pivotal role in viral replication, transcription and assembly. N protein may also play a role in enabling the virus to replicate within host cells (Muyangwa, M).

Hantaviruses are globally distributed zoonotic pathogens. Rodents and small mammals act as natural reservoirs for Hantaviruses but are asymptomatic upon infection. Airborne transmission of hantaviruses to humans occurs via inhalation of dust or aerosols contaminated with urine, saliva or droppings from infected animals. Cases of hantavirus infection are sporadic and predominantly occur in rural areas where rodents are prevalent. Individuals working with rodents are potentially at risk of becoming infected with Hantavirus.

In humans, hantaviruses cause two acute febrile disease syndromes: (1) haemorrhagic fever with renal syndrome (HFRS), mostly caused by Seoul, Puumala and Dobrava viruses, endemic in Europe and Asia; (2) hantavirus cardiopulmonary syndrome (HCPS), which may be caused by Andes virus, Sin Nombre virus, and several others, distributed throughout the Americas.

The clinical symptoms associated with HFRS include fever, renal dysfunction, thrombocytopenia, haemorrhage and shock (CDC). HFRS can be fatal in 1-15% of cases. The symptoms of HCPS are characterised by fever, fatigue, muscle ache, headaches, nausea, vomiting and non-cardiogenic pulmonary oedema. HCPS can be fatal in 38% of reported cases. There is currently no curative treatment for hantavirus infection and eliminating or minimising contact with rodents is the best way to prevent infection.

References

  1. Muyangwa M, et al. (2015). Hantaviral Proteins: Structure, Functions, and Role in Hantavirus Infection. Front Microbiol. Nov 27;6:1326.
  2. Centers for Disease Control and Prevention: Hantavirus

Hantavirus Antibodies

We are pleased to offer a panel of monoclonal antibodies specific to Hantavirus nucleocapsid protein. Each Hantavirus antibody has been developed to recognise the nucleocapsid protein of Hantavirus strains Hantaan, Dobrava, Seoul and Saaremaa.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Zika Prevalence in Suriname – an insight into assay cross-reactivity

A recent study published by Langerak et al tested for the seroprevalence of Zika virus in Suriname populations and evaluated the comparative effectiveness of using a commercial ELISA and a standard Virus Neutralisation Assay. Here we discuss the study, its results,...

What should you call your favourite virus?

The International Committee on Taxonomy of Viruses (ICTV) meet regularly to ensure the taxonomy of viruses is kept logical and up-to-date in the face of an ever-increasing number of new viruses and genome sequences; discussed in here in Nature. This sometimes results...

Overcoming Zika-Dengue cross-reactivity: the highly specific immunoassays your lab needs

In the global battle against Zika virus, serological cross-reactivity with Dengue is a major challenge for academics, epidemiologists and pharmaceutical companies alike. Novel immunoassays can now overcome this problem and could prove a real game-changer in Zika...

The Right Tools for Rubella

Rubella remains a significant pathogen worldwide, with 100,000 cases of congenital rubella syndrome estimated to occur every year. Vaccines to Rubella are highly safe and have effectively eliminated endemic infection in many developed countries, yet inadequate...

Visualising viral infection with immunofluorescence microscopy

Following the latest immunofluoresence data for our Zika and Dengue antibodies, we’ve invited VRS to write a short blog one of their areas of expertise: The applications of immunofluorescence microscopy in studying viruses.   A lot of what we know about biology...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

9 + 4 =

Live Customer Feedback